Trial
NCT00004833
Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Emory University
Collaborators
—
Condition
Guillain-Barre Syndrome
Intervention
Immune globulin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-07